Business Context and Reporting Period
This Form 6-K filing is submitted by Genmab A/S, a foreign private issuer, for the month of March 2026. The report, dated March 30, 2026, serves to incorporate by reference specific corporate announcements into the company's existing registration statements on Form S-8.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing referencing external exhibits rather than a financial statement.
Material Changes
No material financial changes versus the prior comparable period are detailed in the text of this filing. The document focuses on the procedural incorporation of two specific exhibits:
- Exhibit 99.1: Company Announcement Dated March 30, 2026.
- Exhibit 99.2: Orbis Shareholder Notification.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, financial guidance, outlook, risks, contingencies, or unusual items. These details are likely contained within the referenced exhibits (99.1 and 99.2) which are not included in the provided input text.
Key Facts for Investor Verification
- Verify the content of Exhibit 99.1 (Company Announcement) for specific operational or strategic updates.
- Review Exhibit 99.2 (Orbis Shareholder Notification) for details regarding shareholder matters.
- Confirm that this filing incorporates by reference into multiple Form S-8 registration statements (File Nos. 333-232693 through 333-293505).
- Note that no financial data is presented in this specific Form 6-K cover sheet.